Related Experiment Video
Updated: Sep 5, 2025
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
867
Palliation of heart failure: value-based supportive care
Clea Atkinson1,2, Sian Hughes3, Len Richards4
1Palliative and Supportive Care Department, Cardiff and Vale University Health Board, Cardiff, UK clea.atkinson2@wales.nhs.uk.
BMJ Supportive & Palliative Care
|July 5, 2022
Summary
A new Heart Failure Supportive Care Service (HFSCS) improved patient quality of life and reduced hospital admissions. This palliative care model offers significant cost savings, demonstrating value-based care for advanced heart failure (HF).
Area of Science:
- Cardiology
- Palliative Care
- Health Services Research
Background:
- Heart failure (HF) significantly impacts quality of life and symptom burden.
- Existing interventions may not fully address patient priorities in advanced stages.
- The optimal model for delivering palliative care in HF is not yet established.
Purpose of the Study:
- To establish and evaluate a cospeciality, cross-boundary service model for advanced heart failure patients.
- To improve palliative care delivery and patient-centred support.
- To assess the cost-effectiveness of this integrated care model.
Main Methods:
- The Heart Failure Supportive Care Service (HFSCS) was implemented in 2016.
- Patient experience was assessed via questionnaires in 2018 and 2020.
- Hospital admission data (bed days) were statistically compared pre- and post-referral.
Main Results:
- 236 patients were referred to HFSCS between 2016-2020.
- Patients reported compassionate care, improved symptoms (80%), and quality of life (65%).
- HF-related admissions significantly reduced (actual days 18.3 to 4; indexed days 0.05 to 0.032), with estimated savings of ~£2.4 million over 5 years.
Conclusions:
- A cospeciality, cross-boundary care model effectively delivers palliative care benefits to HF patients.
- This approach meets patient priorities and offers value-based care.
- The HFSCS demonstrates a successful integration of palliative and specialized HF care.
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Heart Failure VII: Nursing Interventions
134
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
134
01:30Cardiomyopathy II: Dilated Cardiomyopathy
20
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:30Heart Failure IV: Classification and Diagnostic Evaluation
27
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27